Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2020 Volume 21 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2020 Volume 21 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection

  • Authors:
    • Xin Yang
    • Han‑Mei Wei
    • Guo‑Yan Hu
    • Jun Zhao
    • Li‑Na Long
    • Chang‑Jian Li
    • Zi‑Jun Zhao
    • He‑Kun Zeng
    • Hong Nie
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510700, P.R. China, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, P.R. China, Department of Clinical Laboratory, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510700, P.R. China, Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, Guangdong 510010, P.R. China
    Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1043-1050
    |
    Published online on: January 9, 2020
       https://doi.org/10.3892/mmr.2020.10920
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Oxidative stress is a pathophysiological condition resulting in neurotoxicity, which is possibly associated with neurodegenerative disorders. In this study, the antioxidative effects of the antioxidant astaxanthin (AXT) in combination with huperzine A (HupA), which is used as a cholinesterase inhibitor for the treatment of Alzheimer's disease, were investigated. PC12 cells were treated with either tert‑butyl hydroperoxide (TBHP), or with the toxic version of β‑amyloid, Aβ25‑35, to induce oxidative stress and neurotoxicity. Cell viability, morphology, lactate dehydrogenase (LDH) release, intracellular accumulation of reactive oxygen species (ROS), superoxide dismutase (SOD) activity and malondialdehyde (MDA) content were determined, while neuroprotection was also monitored using an MTT assay. It was found that combining AXT with HupA significantly increased the viability of PC12 cells, prevented membrane damage (as measured by LDH release), attenuated intracellular ROS formation, increased SOD activity and decreased the level of MDA after TBHP exposure when compared to these drugs administered alone. Pretreatment with HupA and AXT decreased toxic damage produced by Aβ25‑35. These data indicated that combining an antioxidant with a cholinesterase inhibitor increases the degree of neuroprotection; with future investigation this could be a potential therapy used to decrease neurotoxicity in the brain.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Migdal C and Serres M: Reactive oxygen species and oxidative stress. Med Sci (Paris). 27:405–412. 2011.(In French). View Article : Google Scholar : PubMed/NCBI

2 

Byun EB, Park WY, Kim WS, Song HY, Sung NY and Byun EH: Neuroprotective effect of Capsicum annuum var. Abbreviatum against hydrogen peroxide-induced oxidative stress in HT22 hippocampus cells. Biosci Biotechnol Biochem. 82:2149–2157. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Sullivan PG, Rabchevsky AG, Waldmeier PC and Springer JE: Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? J Neurosci Res. 79:231–239. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Namioka N, Hanyu H, Hirose D, Hatanaka H, Sato T and Shimizu S: Oxidative stress and inflammation are associated with physical frailty in patients with Alzheimer's disease. Geriater Gerontol Int. 17:913–918. 2017. View Article : Google Scholar

5 

Sankhla CS: Oxidative stress and Parkinson's disease. Neurol India. 65:269–270. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Uttara B, Singh AV, Zamboni P and Mahajan RT: Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 7:65–74. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Wadhwa R, Gupta R and Maurya PK: Oxidative stress and accelerated aging in neurodegenerative and neuropsychiatric disorder. Curr Pharm Des. 24:4711–4725. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Shinotoh H, Namba H, Fukushi K, Nagatsuka S, Tanaka N, Aotsuka A, Ota T, Tanada S and Irie T: Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study. Ann Neurol. 48:194–200. 2000. View Article : Google Scholar : PubMed/NCBI

9 

Mimica N and Presecki P: Side effects of approved antidementives. Psychiat Danub. 21:108–113. 2009.

10 

Cheng DH, Ren H and Tang XC: Huperzine A, a novel promising acetylcholinesterase inhibitor. Neuroreport. 8:97–101. 1996. View Article : Google Scholar : PubMed/NCBI

11 

Wang R, Zhang HY and Tang XC: Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1–40) in rat. Eur J Pharmacol. 421:149–156. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Mei Z, Zheng P, Tan X, Wang Y and Situ B: Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury. Metab Brain Dis. 32:1861–1869. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Xu Z and Wang Y: Huperzine A attenuates hepatic ischemia reperfusion injury via anti-oxidative and anti-apoptotic pathways. Mol Med Rep. 10:701–706. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Shi Q, Fu J, Ge D, He Y, Ran J, Liu Z, Wei J, Diao T and Lu Y: Huperzine A ameliorates cognitive deficits and oxidative stress in the hippocampus of rats exposed to acute hypobaric hypoxia. Neurochem Res. 37:2042–2052. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Pohanka M, Zemek F, Bandouchova H and Pikula J: Toxicological scoring of Alzheimer's disease drug huperzine in a guinea pig model. Toxicol Mech Methods. 22:231–235. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Zhang HY, Zheng CY, Yan H, Wang ZF, Tang LL, Gao X and Tang XC: Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. Chem Biol Interact. 175:396–402. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Gao X and Tang XC: Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J Neurosci Res. 83:1048–1057. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Xiao XQ, Wang R and Tang XC: Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosci Res. 61:564–569. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Xiao XQ, Wang R, Han YF and Tang XC: Protective effects of huperzine A on beta-amyloid(25–35) induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett. 286:155–158. 2000. View Article : Google Scholar : PubMed/NCBI

20 

Saxena G, Singh SP, Agrawal R and Nath C: Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol. 581:283–289. 2008. View Article : Google Scholar : PubMed/NCBI

21 

Ambati RR, Phang SM, Ravi S and Aswathanarayana RG: Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications-a review. Mar Drugs. 12:128–152. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Naguib YM: Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem. 48:1150–1154. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Yang Y, Liu X, Huang J, Zhong Y, Mao Z, Xiao H, Li M and Zhuo Y: Inhibition of p38 mitogen-activated protein kinase phosphorylation decrease tert-butyl hydroperoxide-induced apoptosis in human trabecular meshwork cells. Mol Vis. 18:2127–2136. 2012.PubMed/NCBI

24 

Brookmeyer R, Johnson E, Ziegler-Graham K and Arrighi HM: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3:186–191. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Wu W, Liu BH, Xie CL, Xia XD and Zhang YM: Neuroprotective effects of N-acetyl cysteine on primary hippocampus neurons against hydrogen peroxide-induced injury are mediated via inhibition of mitogen-activated protein kinases signal transduction and antioxidative action. Mol Med Rep. 17:6647–6654. 2018.PubMed/NCBI

26 

Lee JH, Park SY, Shin YW, Kim CD, Lee WS and Hong KW: Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Res. 1185:246–255. 2007. View Article : Google Scholar : PubMed/NCBI

27 

Cachard-Chastel M, Devers S, Sicsic S, Langlois M, Lezoualc'H F, Gardier AM and Belzung C: Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behav Brain Res. 187:455–461. 2008. View Article : Google Scholar : PubMed/NCBI

28 

Ma S, Liu X, Xun Q and Zhang X: Neuroprotective effect of Ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress. Biol Pharm Bull. 37:217–225. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Zhang Z, Lv Z, Shao Y, Qiu Q, Zhang W, Duan X, Li Y and Li C: Microsomal glutathione transferase 1 attenuated ROS-induced lipid peroxidation in Apostichopus japonicus. Dev Comp Immunol. 73:79–87. 2017. View Article : Google Scholar : PubMed/NCBI

30 

Suzuki S, Miyachi Y, Niwa Y and Isshiki N: Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg. 42:559–564. 1989. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yang X, Wei HM, Hu GY, Zhao J, Long LN, Li CJ, Zhao ZJ, Zeng HK and Nie H: Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection. Mol Med Rep 21: 1043-1050, 2020.
APA
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C. ... Nie, H. (2020). Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection. Molecular Medicine Reports, 21, 1043-1050. https://doi.org/10.3892/mmr.2020.10920
MLA
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C., Zhao, Z., Zeng, H., Nie, H."Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection". Molecular Medicine Reports 21.3 (2020): 1043-1050.
Chicago
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C., Zhao, Z., Zeng, H., Nie, H."Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection". Molecular Medicine Reports 21, no. 3 (2020): 1043-1050. https://doi.org/10.3892/mmr.2020.10920
Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Wei HM, Hu GY, Zhao J, Long LN, Li CJ, Zhao ZJ, Zeng HK and Nie H: Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection. Mol Med Rep 21: 1043-1050, 2020.
APA
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C. ... Nie, H. (2020). Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection. Molecular Medicine Reports, 21, 1043-1050. https://doi.org/10.3892/mmr.2020.10920
MLA
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C., Zhao, Z., Zeng, H., Nie, H."Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection". Molecular Medicine Reports 21.3 (2020): 1043-1050.
Chicago
Yang, X., Wei, H., Hu, G., Zhao, J., Long, L., Li, C., Zhao, Z., Zeng, H., Nie, H."Combining antioxidant astaxantin and cholinesterase inhibitor huperzine A boosts neuroprotection". Molecular Medicine Reports 21, no. 3 (2020): 1043-1050. https://doi.org/10.3892/mmr.2020.10920
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team